21468126

Source:http://linkedlifedata.com/resource/pubmed/id/21468126

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0008059, umls-concept:C0019196, umls-concept:C0042721, umls-concept:C1522326
pubmed:issue	5
pubmed:dateCreated	2011-6-21
pubmed:abstractText	Most children with chronic hepatitis C have minimal liver disease before adulthood, but could be at risk of progression to cirrhosis and hepatocellular carcinoma because of persistent virus replication. The results of the first controlled trial with PEG-IFN-?2a plus ribavirin are a step towards an appropriate treatment for these children.
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/21468126-21036173
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/101500079
pubmed:status	PubMed-not-MEDLINE
pubmed:month	May
pubmed:issn	1759-5053
pubmed:author	pubmed-author:BortolottiFlaviaF, pubmed-author:GuidoMariaM
pubmed:issnType	Electronic
pubmed:volume	8
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	247-8
pubmed:year	2011
pubmed:articleTitle	Viral hepatitis: Treating hepatitis C in children: an open horizon.
pubmed:affiliation	Department of Medical Sciences and Special Therapies, Pathology Unit, University of Padova, Via Gabelli 61, Padua, Italy. mguido@unipd.it
pubmed:publicationType	Journal Article, Comment